COMUNICADO: Plavix(R) Indications Expanded in Japan to Include Patients with Acute Coronary Syndrome for Whom Percutaneous Coronary

Actualizado 22/10/2007 5:02:55 CET

This press release contains forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995, as amended. Forward-looking statements are statements that are not historical facts. These statements include financial projections and estimates and their underlying assumptions, statements regarding plans, objectives, intentions and expectations with respect to future events, operations, products and services, and statements regarding future performance. Forward-looking statements are generally identified by the words "expects," "anticipates," "believes," "intends," "estimates," "plans" and similar expressions. Although sanofi-aventis' management believes that the expectations reflected in such forward-looking statements are reasonable, investors are cautioned that forward-looking information and statements are subject to various risks and uncertainties, many of which are difficult to predict and generally beyond the control of sanofi-aventis, that could cause actual results and developments to differ materially from those expressed in, or implied or projected by, the forward-looking information and statements. These risks and uncertainties include those discussed or identified in the public filings with the SEC and the AMF made by sanofi-aventis, including those listed under "Risk Factors" and "Cautionary Statement Regarding Forward-Looking Statements" in sanofi-aventis' annual report on Form 20-F for the year ended December 31, 2006. Other than as required by applicable law, sanofi-aventis does not undertake any obligation to update or revise any forward-looking information or statements.


References:
1 Guidelines for Management of Acute Coronary Syndrome without Persistent
ST segment Elevation (JCS 2002, Circulation Journal Vol.66, Suppl. IV.
2002, pp.1123-1163)
2 Guidelines for management of anticoagulant and antiplatelet therapy in
cardiovascular disease (JCS 2004, Circulation Journal Vol.68, Suppl.
IV, 2004, pp.1153-1219)
3 The American College of Cardiology/The American Heart Association
4 ACC/AHA 2007 Guidelines for the Management of Patients With Unstable
Angina/Non-ST-Elevation Myocardial Infarction: Circulation 116: 803 -
877, 2007
5 The American College of Cardiology/The American Heart Association/The
Society of Cardiovascular Angiography and Interventions
6 ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary
Intervention: Circulation 113(7): e166 - e286, 2006
7 The European Society of Cardiology
8 Guidelines for the diagnosis and treatment of non-ST-segment elevation
acute coronary syndromes: Eur Heart J. 28(13): 1598-1660, 2007

Web site: http://www.sanofi-aventis.com

Philippe Barquet, +33-6-70-48-61-28, for sanofi-aventis; Media Relations, +33-1-53-77-44-50, media-relations@sanofi-aventis.com, or Investor Relations, +33-1-53-77-45-45, IR@sanofi-aventis.com, both of sanofi-aventis

Mejora la comunicación de tu empresa con Europa Press Comunicación

Esta web utiliza cookies propias y de terceros para analizar su navegación y ofrecerle un servicio más personalizado y publicidad acorde a sus intereses. Continuar navegando implica la aceptación de nuestra política de cookies -
Uso de cookies